Author:
Ide Soichiro,Minami Masabumi,Satoh Masamichi,Uhl George R,Sora Ichiro,Ikeda Kazutaka
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference39 articles.
1. Blake AD, Bot G, Freeman JC, Reisine T (1997). Differential opioid agonist regulation of the mouse mu opioid receptor. J Biol Chem 272: 782–790.
2. Bot G, Blake AD, Li S, Reisine T (1998). Mutagenesis of the mouse delta opioid receptor converts (−)-buprenorphine from a partial agonist to an antagonist. J Pharmacol Exp Ther 284: 283–290.
3. Cheskin LJ, Fudala PJ, Johnson RE (1994). A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Drug Alcohol Depend 36: 115–121.
4. Comer SD, Collins ED, Fischman MW (2002). Intravenous buprenorphine self-administration by detoxified heroin abusers. J Pharmacol Exp Ther 301: 266–276.
5. Cowan A, Lewis JW, Macfarlane IR (1977). Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 60: 537–545.
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献